NCT00002909View on ClinicalTrials.gov

Phenylbutyrate in Treating Patients With Refractory Solid Tumors or Lymphoma

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 28, 1997

Primary Completion Date

October 31, 2000

Conditions
LymphomaUnspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

chemotherapy

DRUG

oral sodium phenylbutyrate

Trial Locations (1)

21287

Johns Hopkins Oncology Center, Baltimore

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00002909 - Phenylbutyrate in Treating Patients With Refractory Solid Tumors or Lymphoma | Biotech Hunter | Biotech Hunter